TUMOR-NECROSIS-FACTOR-ALPHA INDUCES P53-DEPENDENT APOPTOSIS IN RAT GLIOMA-CELLS

被引:39
作者
YIN, DL
KONDO, S
BARNETT, GH
MORIMURA, T
TAKEUCHI, J
机构
[1] CLEVELAND CLIN FDN,DEPT NEUROSURG,CTR BRAIN TUMOR,CTR CANC,CLEVELAND,OH 44195
[2] NATL UTANO HOSP,DEPT NEUROSURG,KYOTO,JAPAN
关键词
APOPTOSIS; GLIOMA; MUTANT P53; TUMOR NECROSIS FACTOR-ALPHA; WILD-TYPE P53;
D O I
10.1227/00006123-199510000-00021
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IN THIS STUDY, we demonstrated that tumor necrosis factor (TNF)-alpha inhibited the viability of rat glioma (C6) cells and induced apoptosis but did not affect the viability of rat newborn brain, mainly astroglial cells. The antitumor activity of TNF-alpha against C6 cells was partially inhibited by actinomycin D and cycloheximide, suggesting that it is possibly dependent upon new ribonucleic acid and protein synthesis. The results of immunoblotting assay demonstrated that TNF-alpha decreased the expression of mutant p53 protein but induced the expression of wild-type p53 in C6 cells during apoptosis. We suggest that TNF-alpha may activate the function of wild-type p53 protein by the suppression of mutant p53, at least indirectly, and induce p53-dependent apoptosis in glioma cells.
引用
收藏
页码:758 / 762
页数:5
相关论文
共 47 条
[1]   MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY [J].
BARAK, Y ;
JUVEN, T ;
HAFFNER, R ;
OREN, M .
EMBO JOURNAL, 1993, 12 (02) :461-468
[2]   TUMOR NECROSIS FACTOR [J].
BRENNER, MK .
BRITISH JOURNAL OF HAEMATOLOGY, 1988, 69 (02) :149-152
[3]   DEVELOPMENTAL CELL-DEATH - MORPHOLOGICAL DIVERSITY AND MULTIPLE MECHANISMS [J].
CLARKE, PGH .
ANATOMY AND EMBRYOLOGY, 1990, 181 (03) :195-213
[4]   EFFECTS OF CYCLOHEXIMIDE ON B-CHRONIC LYMPHOCYTIC LEUKEMIC AND NORMAL LYMPHOCYTES INVITRO - INDUCTION OF APOPTOSIS [J].
COLLINS, RJ ;
HARMON, BV ;
SOUVLIS, T ;
POPE, JH ;
KERR, JFR .
BRITISH JOURNAL OF CANCER, 1991, 64 (03) :518-522
[5]   P53 FUNCTIONS AS A CELL-CYCLE CONTROL PROTEIN IN OSTEOSARCOMAS [J].
DILLER, L ;
KASSEL, J ;
NELSON, CE ;
GRYKA, MA ;
LITWAK, G ;
GEBHARDT, M ;
BRESSAC, B ;
OZTURK, M ;
BAKER, SJ ;
VOGELSTEIN, B ;
FRIEND, SH .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (11) :5772-5781
[6]  
EASTMAN A, 1990, CANCER CELL-MON REV, V2, P275
[7]   WILD-TYPE P53 CAN INHIBIT ONCOGENE-MEDIATED FOCUS FORMATION [J].
ELIYAHU, D ;
MICHALOVITZ, D ;
ELIYAHU, S ;
PINHASIKIMHI, O ;
OREN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :8763-8767
[8]  
FEINSTEIN E, 1992, ONCOGENE, V7, P1853
[9]   ACTIVATING MUTATIONS FOR TRANSFORMATION BY P53 PRODUCE A GENE-PRODUCT THAT FORMS AN HSC70-P53 COMPLEX WITH AN ALTERED HALF-LIFE [J].
FINLAY, CA ;
HINDS, PW ;
TAN, TH ;
ELIYAHU, D ;
OREN, M ;
LEVINE, AJ .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (02) :531-539
[10]   THE P53 PROTO-ONCOGENE CAN ACT AS A SUPPRESSOR OF TRANSFORMATION [J].
FINLAY, CA ;
HINDS, PW ;
LEVINE, AJ .
CELL, 1989, 57 (07) :1083-1093